| Title | Author(s) | Year | View Count |
 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in Hepatocellular carcinoma development | Yip, WK; Cheng, ASL; Zhu, R; Lung, RWM; Tsang, DPF; Lau, SSK; Chen, Y; Sung, JG; Lai, PBS; Ng, EKO; Yu, J; Wong, N; To, KF; Wong, VWS; Sung, JJY; Chan, HLY | 2011 | 117 |
 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score | Yang, HI; Yuen, MF; Chan, HLY; Han, KH; Chen, PJ; Kim, DY; Ahn, SH; Chen, CJ; Wong, VWS; Seto, WK | 2011 | 999 |
| Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn, SH; Chan, HLY; Chen, PJ; Cheng, J; Goenka, MK; Hou, J; Lim, SG; Omata, M; Piratvisuth, T; Xie, Q; Yim, HJ; Yuen, MF | 2010 | 145 |
| High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B | Wong, VWS; Yu, J; Cheng, ASL; Wong, GLH; Chan, HY; Chu, ESH; Ng, EKO; Chan, FKL; Sung, JJY; Chan, HLY | 2009 | 195 |
| High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome | Dong, Q; Liu, Z; Chen, Y; Chan, CY; Lin, MC; Kung, Hf; Chan, HLY; Sung, JJY; He, ML | 2009 | 146 |
| Efficacy of cap-assisted colonoscopy in comparison with regular colonoscopy: A randomized controlled trial | Lee, YT; Lai, LH; Hui, AJ; Wong, VWS; Ching, JYL; Wong, GLH; Wu, JCY; Chan, HLY; Leung, WK; Lau, JYW; Sung, JJY; Chan, FKL | 2009 | 106 |
| Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study | Lee, YT; Chan, FKL; Leung, WK; Chan, HLY; Wu, JCY; Yung, MY; Ng, EKW; Lau, JYW; Sung, JJY | 2008 | 82 |
| Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial | Chan, HLY; Heathcote, EJ; Marcellin, P; Lai, CL; Cho, M; Moon, YM; Chao, YC; Myers, RP; Minuk, GY; Jeffers, L; Sievert, W; Bzowej, N; Harb, G; Kaiser, R; Qiao, XJ; Brown, NA; Crawford, D; Lim, SG; Chutaputti, A; Poynard, T | 2007 | 138 |
| Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis | Yu, J; Hui, AY; Chu, ESH; Cheng, ASL; Go, MYY; Chan, HLY; Leung, WK; Cheung, KF; Ching, AKK; Chui, YL; Chan, KK; Sung, JJY | 2007 | 56 |
 | 76 week follow up of HBeAg-positive chronic hepatitis B patients treated with telbivudine, adefovir or switched from adefovir to telbivudine | Marcellin, P; Chan, HLY; Lai, CL; Cho, M; Moon, YM; Chao, YC; Heathcote, J; Myers, R; Harb, G; Brown, NA | 2007 | 117 |
| In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy | Marcellin, P; Chan, HLY; Lai, CL; Clio, M; Heathcote, I; Moon, YM; Chao, YC; Myers, R; Harb, G; Brown, NA | 2007 | 100 |
| Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial | Chan, FKL; Wong, VWS; Suen, BY; Wu, JCY; Ching, JYL; Hung, LCT; Hui, AJ; Leung, VKS; Lee, VWY; Lai, LH; Wong, GLH; Chow, DKL; To, KF; Leung, WK; Chiu, PWY; Lee, YT; Lau, JYW; Chan, HLY; Ng, EKW; Sung, JJY | 2007 | 73 |
| Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis | Yu, J; Chu, ESH; Hui, AY; Cheung, KF; Chan, HLY; Leung, WK; Farrell, GC; Sung, JJY | 2007 | 97 |
| A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 results | Bzowej, N; Chan, HLY; Lai, CL; Cho, M; Moon, YM; Chao, YC; Heathcote, EJ; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Harb, G; Chao, GC; Brown, NA | 2006 | 157 |
| A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis | Chan, HLY; Lai, CL; Cho, M; Heathcote, J; Moon, Y-M; Chao, Y-C; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Chao, G; Brown, N | 2006 | 123 |
| Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding | Chan, FKL; Ching, JYL; Hung, LCT; Wong, VWS; Leung, VKS; Kung, NNS; Hui, AJ; Wu, JCY; Leung, WK; Lee, VWY; Lee, KKC; Lee, YT; Lau, JYW; To, KF; Chan, HLY; Chung, SCS; Sung, JJY | 2005 | 115 |
| Clinical significance of hepatic derangement in severe acute respiratory syndrome | Chan, HLY; Kwan, ACP; To, KF; Lai, ST; Chan, PKS; Leung, WK; Lee, N; Wu, A; Sung, JJY | 2005 | 64 |
| Transmission of hepatitis B by human bite - Confirmation by detection of virus in saliva and full genome sequencing | Hui, AY; Hung, LCT; Tse, PCH; Leung, WK; Chan, PKS; Chan, HLY | 2005 | 61 |
| Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: A prospective cohort study | Hung, LCT; Ching, JYL; Sung, JJY; To, KF; Hui, AJ; Wong, VWS; Leong, RWL; Chan, HLY; Wu, JCY; Leung, WK; Lee, YT; Chung, SCS; Chan, FKL | 2005 | 54 |
| Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell | Chor, SY; Hui, AY; To, KF; Chan, KK; Go, YY; Chan, HLY; Leung, WK; Sung, JJY | 2005 | 62 |
|
